Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission

Acta Tropica

Volumn 136, Issue 1, 2014, Pages 89-100

  Valizadeh, Vahideh ^a   Zakeri, Sedigheh ^a   Mehrizi, Akram Abouei ^a   Djadid, Navid Dinparast ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cross reactive antibody; Duffy binding protein; Iran; Plasmodium vivax; Vaccine

Indexed keywords

DUFFY BINDING PROTEIN; EPITOPE; IMMUNOGLOBULIN G; AMINO ACID ACETYLTRANSFERASE; CELL SURFACE RECEPTOR; DUFFY ANTIGEN BINDING PROTEIN, PLASMODIUM; MALARIA VACCINE; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ANTIBODY; DISEASE TRANSMISSION; IMMUNE RESPONSE; MALARIA; PATHOGEN; PROTEIN; VACCINE;

ADOLESCENT; ADULT; ALLELE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; CROSS REACTION; DUFFY BINDING PROTEIN GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IRAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE TRANSMISSION; PLASMODIUM VIVAX MALARIA; PROTEIN DOMAIN; SEQUENCE ANALYSIS; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; EPIDEMIOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALARIA, VIVAX; METABOLISM; MOLECULAR GENETICS; PARASITOLOGY; PLASMODIUM VIVAX; SEASON;

IRAN;

AMINO-ACID N-ACETYLTRANSFERASE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; EPITOPES, B-LYMPHOCYTE; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; IRAN; MALARIA VACCINES; MALARIA, VIVAX; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; SEASONS;

EID: 84899870482     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2014.03.019     Document Type: Article

References (62)

1. Adams J.H., Hudson D.E., Torii M., Ward G.E., Wellems T.E., Aikawa M., Miller L.H. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 1990, 63:141-153.
2. Ampudia E., Patarroyo M.A., Patarroyo M.E., Murillo L.A. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol. Biochem. Parasitol. 1996, 78:269-272.
3. Babaeekho L., Zakeri S., Djadid N.D. Genetic mapping of the duffy binding protein (DBP) ligand domain of Plasmodium vivax from unstable malaria region in the Middle East. Am. J. Trop. Med. Hyg. 2009, 80:112-118.
4. Barnwell J.W., Galinski M.R. Plasmodium vivax: a glimpse into the unique and shared biology of the merozoite. Ann. Trop. Med. Parasitol. 1995, 89:113-120.
5. Cavasini C.E., Mattos L.C., Couto A.A., Bonini-Domingos C.R., Valencia S.H., Neiras W.C., Alves R.T., Rossit A.R., Castilho L., Machado R.L. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception?. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1042-1044.
6. Ceravolo I.P., Souza-Silva F.A., Fontes C.J., Braga E.M., Madureira A.P., Krettli A.U., Souza J.M., Brito C.F., Adams J.H., Carvalho L.H. Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand. J. Immunol. 2008, 67:270-278.
7. Chitnis C.E., Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 1994, 180:497-506.
8. Chitnis C.E., Chaudhuri A., Horuk R., Pogo A.O., Miller L.H. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med. 1996, 184:1531-1536.
9. Chitnis C.E., Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol. 2008, 24:29-34.
10. Chootong P., Ntumngia F.B., VanBuskirk K.M., Xainli J., Cole-Tobian J.L., Campbell C.O., Fraser T.S., King C.L., Adams J.H. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect. Immun. 2010, 78:1089-1095.
11. Chootong P., Panichakul T., Permmongkol C., Barnes S.J., Udomsangpetch R., Adams J.H. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand. PLoS ONE 2012, 7:e35769.
12. Cole-Tobian J.L., Cortés A., Baisor M., Kastens W., Xainli J., Bockarie M., Adams J.H., King C.L. Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein. J. Infect. Dis. 2002, 186:531-539.
13. Cole-Tobian J.L., Michon P., Dabod E., Mueller I., King C.L. Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children. Am. J. Trop. Med. Hyg. 2007, 75:955-962.
14. Cole-Tobian J.L., Michon P., Biasor M., Richards J.S., Beeson J.G., Mueller I., King C.L. Strain-specific Duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous Plasmodium vivax strains in Papua New Guinean children. Infect. Immun. 2009, 77:4009-4017.
15. Collins W.E., Jeffery G.M. Primaquine resistance in Plasmodium vivax. Am. J. Trop. Med. Hyg. 1996, 55:243-249.
16. Ferreira M.U., da Silva Nunes M., Wunderlich G. Antigenic diversity and immune evasion by malaria parasites. Clin. Diagn. Lab. Immunol. 2004, 11:987-995.
17. Galinski M.R., Barnwell J.W. Monkey malaria kills four humans. Trends Parasitol. 2009, 25:200-204.
18. Genton B., Betuela I., Felger I., Al-Yaman F., Anders R.F., Saul A., Rare L., Baisor M., Lorry K., Brown G.V., Pye D., Irving D.O., Smith T.A., Beck H.P., Alpers M.P. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 2002, 185:820-827.
19. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., Müller I. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008, 5:e12712.
20. Gosi P., Khusmith S., Khalambaheti T., Lanar D.E., Schaecher K.E., Fukuda M.M., Miller S.R. Polymorphisms of Plasmodium vivax duffy binding protein in isolates from Thai patients. Malar. J. 2008, 7:112.
21. Grimberg B.T., Udomsangpetch R., Xainli J., McHenry A., Panichakul T., Sattabongkot J., Cui L., Bockarie M., Chitnis C., Adams J., Zimmerman P.A., King C.L. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 2007, 4:e337.
22. Hans D., Pattnaik P., Bhattacharyya A., Shakri A.R., Yazdani S.S., Sharma M., Choe H., Farzan M., Chitnis C.E. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol. Microbiol. 2005, 55:1423-1434.
23. John C.C., O'Donnell R.A., Sumba P.O., Moormann A.M., de Koning-Ward T.F., King C.L., Kazura J.W., Crabb B.S. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-119) can play a protective role against blood stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J. Immunol. 2004, 173:666-672.
24. Ju H.L., Kang J.M., Moon S.U., Kim J.Y., Lee H.W., Lin K., Sohn W.M., Lee J.S., Kim T.S., Na B.K. Genetic polymorphism and natural selection of Duffy binding protein of Plasmodium vivax Myanmar isolates. Malar. J. 2012, 11:60.
25. Ju H.L., Kang J.M., Moon S.U., Bahk Y.Y., Cho P.Y., Sohn W.M., Park Y.K., Park J.W., Kim T.S., Na B.K. Genetic diversity and natural selection of Duffy binding protein of Plasmodium vivax Korean isolates. Acta Trop. 2013, 125:67-74.
26. Kho W.G., Chung J.Y., Sim E.J., Kim D.W., Chung W.C. Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates. Korean J. Parasitol. 2001, 39:143-150.
27. King C.L., Michon P., Shakri A.R., Marcotty A., Stanisic D., Zimmerman P.A., Cole-Tobian J.L., Mueller I., Chitnis C.E. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8363-8368.
28. List C., Qi W., Maag E., Gottstein B., Müller N., Felger I. Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray. PLoS Negl. Trop. Dis. 2010, 4:e771.
29. Mamillapalli A., Sunil S., Diwan S.S., Sharma S.K., Tyagi P.K., Adak T., Joshi H., Malhotra P. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates. Malar. J. 2007, 6:95.
30. McHenry A.M., Barnes S.J., Ntumngia F.B., King C.L., Adams J.H. Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein. PLoS ONE 2011, 6:e20192.
31. Ménard D., Barnadas C., Bouchier C., Henry-Halldin C., Gray L.R., Ratsimbasoa A., Thonier V., Carod J.F., Domarle O., Colin Y., Bertrand O., Picot J., King C.L., Grimberg B.T., Mercereau-Puijalon O., Zimmerman P.A. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5967-5971.
32. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 2001, 64:97-106.
33. Michon P., Fraser T., Adams J.H. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect. Immun. 2000, 68:3164-3171.
34. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 1976, 295:302-304.
35. Ntumngia F.B., Schloegel J., Barnes S.J., McHenry A.M., Singh S., King C.L., Adams J.H. Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies. Infect. Immun. 2012, 80:1203-1208.
36. Ntumngia F.B., Adams J.H. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein. Clin. Vaccine Immunol. 2012, 19:30-36.
37. Polley S.D., Tetteh K.K., Lloyd J.M., Akpogheneta O.J., Greenwood B.M., Bojang K.A., Conway D.J. Plasmodium falciparum merozoite surface protein is a target of allele-specific immunity and allele are maintained by natural selection. J. Infect. Dis. 2007, 195:279-287.
38. Premaratne P.H., Aravinda B.R., Escalante A.A., Udagama P.V. Genetic diversity of Plasmodium vivax Duffy Binding Protein II (PvDBP-II) under unstable transmission and low intensity malaria in Sri Lanka. Infect. Genet. Evol. 2011, 11:1327-1339.
39. Ryan J.R., Stoute J.A., Amon J., Dunton R.F., Mtalib R., Koros J., Owour B., Luckhart S., Wirtz R.A., Barnwell J.W., Rosenberg R. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am. J. Trop. Med. Hyg. 2006, 75:575-581.
40. Saha S., Raghava G.P. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 2006, 65:40-48.
41. San Sebastián M., Játiva R., Goicolea I. Epidemiology of malaria in the Amazon basin of Ecuador. Rev. Panam. Salud Publica 2000, 7:24-28.
42. Sharma V.P. Current scenario of malaria in India. Parassitologia 1999, 41:349-353.
43. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., Hawley W.A., Kaslow D.C., Nahlen B.L., Lal A.A. Natural immune response to the Cterminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 1996, 64:2716-2723.
44. Siddiqui A.A., Xainli J., Schloegel J., Carias L., Ntumngia F., Shoham M., Casey J.L., Foley M., Adams J.H., King C.L. Fine specificity of Plasmodium vivax duffy binding protein binding engagement of the duffy antigen on human erythrocytes. Infect. Immun. 2012, 80:2920-2928.
45. Sim B.K., Orlandi P.A., Haynes J.D., Klotz F.W., Carter J.M., Camus D., Zegans M.E., Chulay J.D. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J. Cell Biol. 1990, 111:1877-1884.
46. Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994, 264:1941-1944.
47. Singh A.P., Puri S.K., Chitnis C.E. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. Mol. Biochem. Parasitol. 2002, 121:21-31.
48. Singh A.P., Ozwara H., Kocken C.H., Puri S.K., Thomas A.W., Chitnis C.E. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Mol. Microbiol. 2005, 55:1925-1934.
49. Singh S.K., Hora R., Belrhali H., Chitnis C.E., Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 2006, 439:741-744.
50. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
51. Sousa T.N., Cerávolo I.P., Fernandes Fontes C.J., Couto A., Carvalho L.H., Brito C.F. The pattern of major polymorphisms in the Duffy binding protein ligand domain among Plasmodium vivax isolates from the Brazilian Amazon area. Mol. Biochem. Parasitol. 2006, 146:251-254.
52. Sutton P.L., Clark E.H., Silva C., Branch O.H. The Plasmodium falciparum merozoite surface protein-1 19KD antibody response in the Peruvians Amazon predominantly targets the non-allele specific, shared sites of this antigen. Malar. J. 2010, 9:3.
53. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5:e128.
54. Tsuboi T., Kappe S.H., al-Yaman F., Prickett M.D., Alpers M., Adams J.H. Natural variation within the principal adhesion domain of the Plasmodium vivax Duff binding protein. Infect. Immun. 1994, 62:5581-5586.
55. VanBuskirk K.M., Sevova E., Adams J.H. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15754-15759.
56. VanBuskirk K.M., Cole-Tobian J.L., Baisor M., Sevova E.S., Bockarie M., King C.L., Adams J.H. Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J. Infect. Dis. 2004, 190:1556-1562.
57. Xainli J., Adams J.H., King C.L. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol. Biochem. Parasitol. 2000, 111:253-260.
58. Xainli J., Cole-Tobian J.L., Baisor M., Kastens W., Bockarie M., Yazdani S.S., Chitnis C.E., Adams J.H., King C.L. Epitope-specific humoral immunity to Plasmodium vivax duffy binding protein. Infect. Immun. 2003, 71:2508-2515.
59. Yang Z.R., Thomson R., McNeil P., Esnouf R.M. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 2005, 21:3369-3376.
60. Yazdani S.S., Shakri A.R., Chitnis C.E. A high cell density fermentation strategy to produce recombinant malarial antigen in E. coli. Biotechnol. Lett. 2004, 26:1891-1895.
61. Zakeri S., Mehrizi A.A., Zoghi S., Djadid N.D. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-119) in Iranians exposed to unstable malaria transmission. Malar. J. 2010, 9:257.
62. Zakeri S., Babaeekhou L., Mehrizi A.A., Abbasi M., Djadid N.D. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission. Am. J. Trop. Med. Hyg. 2011, 84:944-950.